By: Sara Riascos  Apr. 19, 2022

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Cefuroxime is an antibiotic used to treat bacterial infections of the ear, nose, throat, lungs, skin, bones, joints, bladder, or kidneys. Cefuroxime is the most commonly used antibiotic in the treatment of acute COPD exacerbation.

By: Sara Riascos  Apr. 01, 2022

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payors such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing.Ventolin (Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.

By: Sara Riascos  Mar. 31, 2022

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing.Ventolin(Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.

By: Sara Riascos  Mar. 28, 2022

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Symbicort (Budesonide/Formoterol) Symbicort (Budesonide / Formoterol) is an inhaled glucocorticoid and long acting beta-2-agonist. Studies have shown that the use of Symbicort (Budesonide / Formoterol) minimizes the risk of readmission compared to other treatments for Chronic obstructive pulmonary disease (COPD). Other studies have shown the use of Symbicort (Budesonide/Formoterol) reduces the annual rate and severity of exacerbations caused by Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD).

By: Sara Riascos  Mar. 25, 2022

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Ventolin (Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.

By: Sara Riascos  Mar. 15, 2022

Chronic Obstructive Pulmonary Disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Ventolin (Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than four.

By: Sara Riascos  Mar. 14, 2022

Chronic Obstructive Pulmonary Disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing.Ventolin (Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic Obstructive Pulmonary Disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4.

By: Sara Riascos  Mar. 08, 2022

Background:

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Ventolin(Albuterol) is an Inhaled beta-2-agonist. Studies have shown the use of Ventolin (Albuterol) had an improvement in Chronic obstructive pulmonary disease (COPD) compared to the baseline. Other studies have shown the use of Ventolin (Albuterol) is safe for patients older than 4

By: Sara Riascos  Mar. 04, 2022

Chronic obstructive pulmonary disease (COPD) is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Symbicort (Budesonide/Formoterol) is an inhaled glucocorticoid and long acting beta-2-agonist.Studies have shown that the use of Symbicort (Budesonide / Formoterol) minimizes the risk of readmission compared to other treatments for Chronic obstructive pulmonary disease (COPD). Other studies have shown the use of Symbicort (Budesonide/Formoterol) l reduces the annual rate and severity of exacerbations caused by Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease (COPD). Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of Symbicort (Budesonide / Formoterol) within 7 days of hospitalization was associated with lower hospital readmission rates for Chronic obstructive pulmonary disease (COPD).

By: Sara Riascos  Mar. 02, 2022

Background:

Pneumonia is frequently associated with hospital readmission. Readmission is a hospital quality measure that reflects dimensions of quality of inpatient care and also impacts overall programs by payers such as CMS’s Star Rating Program, HRRP and Value-Based Purchasing. Cefdinir is an antibiotic that is used to treat many different types of infections caused by bacteria.Studies have shown that cefdinir is effective and safe when treating patients with pneumonia. Dexur’s analysis of Real-World Evidence based on Medicare Claims data showed that the use of Cefdinir within 7 days of hospitalization was associated with lower hospital readmission rates for Pneumonia at Carson Tahoe Regional Medical Center in Carson City, Nevada. Reduction in readmission rates helps hospitals improve their outcomes for various cost and quality programs. Dexur is an approved entity to perform Medicare claims data analysis, which it uses to perform quality outcomes analysis. Dexur has published several papers with Harvard Medical School on quality outcomes related topics. Dexur’s analysis of Drugs and their impact on quality outcomes, such as readmissions and mortality, are used by Hospitals, IDNs, and ACOs to implement best practices and manage Real World Evidence based risk factors.